Company: REVB
Filing Date: 2025-09-12
Form Type: PRE 14A
Source: 0000950170-25-114524
Chunk: 14

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-09-12
Form: PRE 14A
Chunk 14
---
 adjourned, to the extent necessary for us to solicit additional proxies in favor of the adoption of any such proposal.

Required Vote and Recommendation

The affirmative vote majority of the number of shares of common stock entitled to vote thereon and present (either in person or by proxy).

Board Recommendation

The board of directors unanimously recommends a vote “FOR” Proposal 2.

<div align='center'>8</div>

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The following table also sets forth information known to us regarding the beneficial ownership of our common stock as of September 11, 2025: • each person who is, or is expected to be, the beneficial owner of more than 5% of the outstanding shares of our common stock or preferred stock; • each of our current officers and directors; and • all current executive officers and directors of the Company, as a group. Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days. Shares of common stock issuable pursuant to options or warrants are deemed to be outstanding for purposes of computing the beneficial ownership percentage of the person or group holding such options or warrants but are not deemed to be outstanding for purposes of computing the beneficial ownership percentage of any other person. The beneficial ownership of our common stock is based on 2,339,306 shares of common stock outstanding as of September 11, 2025. Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all shares of stock owned by them.

| Name                                                     |     | Number of Shares   
 Beneficially Owned |         |     | Beneficial    
 Ownership (%) |      |   |
| Armistice Capital Master Fund Ltd.(1)                    |     |                    | 233,696 |     |               | 9.99 | % |
| Directors and Officers of Revelation(2):                 |     |                    |         |     |               |      |   |
| James Rolke(3)                                           |     |                    |  10,047 |     |               |    * |   |
| Jennifer Carver, BSN, MBA(5)                             |     |                    |      67 |     |               |    * |   |
| Jess Roper(6)